American Society of Hirudotherapy

A systematic review and meta-analysis of medical leech therapy for osteoarthritis of the knee

Lauche R, Cramer H, Langhorst J, Dobos G (2014) · The Clinical Journal of Pain · n=237

Review: Off-label use means application outside the FDA-cleared indication. Clinical evidence (RCTs or systematic reviews) supports this use, but the FDA has not cleared it.Study record: Content describes science, methodology, or organizational reference material — not a clinical efficacy claim.
GRADE ModerateMeta-analysisCondition: Knee Osteoarthritis →

Study Profile

Design
systematic review and meta-analysis of randomized and nonrandomized controlled clinical trials of medical leech therapy for knee OA
Pooled sample (n; included studies may overlap)
237
Scope
Pooled analysis of 3 RCTs and 1 controlled clinical trial of medicinal leech therapy in knee OA (Michalsen 2003, Andereya 2008, Stange 2011/2012, plus one CCT)
Main result
Strong evidence for immediate (SMD=-1.05; p<0.01) and short-term pain reduction (SMD=-1.00; p<0.01); immediate improvement in physical function (SMD=-0.72; p<0.01); both immediate (SMD=-0.88; p=0.04) and long-term improvement in joint stiffness (SMD=-0.62; p<0.01); moderate evidence for short-term function (SMD=-0.46) and long-term pain (SMD=-0.45)

Key Findings

  • First systematic review and meta-analysis of leech therapy for knee OA (pre-dating Wang 2018)
  • Pooled n=237 across 3 RCTs and 1 CCT showed strong evidence for pain reduction, functional improvement, and stiffness reduction
  • Standardized mean difference (SMD) for immediate pain reduction was -1.05, a large effect by Cohen's conventional thresholds
  • Three of four included trials had low risk of bias per the authors' assessment
  • No serious adverse events reported in the pooled cohort

Limitations

  • Only 4 included trials at the time of analysis (2012 search) - small evidence base
  • All included trials open-label - no sham-controlled trial was available for pooling
  • Heterogeneous comparators (topical diclofenac, HA, NSAIDs, TENS) reduce interpretability
  • Authors note that further high-quality RCTs are needed for conclusive judgment
  • Geographic bias - most included trials German

Clinical Implications

Lauche 2014 meta-analysis is the foundational quantitative synthesis of the German leech-OA literature and supports the GRADE 'moderate' rating that the ASH editorial board applies to knee OA. The standardized mean difference of -1.05 for immediate pain (large effect) is one of the strongest pooled effects reported for any non-pharmacologic OA intervention. Clinicians citing the leech-knee-OA evidence should cite this meta-analysis alongside the underlying RCTs (Michalsen 2003, Andereya 2008, Stange 2011/2012). The meta-analysis was updated by Wang 2018 with similar conclusions.

Related studies

This website provides educational information and does not constitute medical advice, diagnosis, or treatment recommendations. Medicinal leech therapy carries clinically meaningful risks and should be performed only by qualified clinicians under institutionally approved protocols. FDA 510(k) clearance for medicinal leeches is limited to specific indications; investigational and off-label discussions are labeled accordingly. For patient-specific guidance, consult a qualified healthcare provider.